Congenital heart? block (CHB), detected at or before birth in a structurall
y normal heart, is strongly associated with autoantibodies reactive with th
e intracellular soluble ribonucleoproteins 48kD SSB/La, 52kD SSA/Ro, and 60
kD SSA/Ro, CHB is presumed to be due to the transplacental passage of autoa
ntibodies front the mother into the fetal circulation, Varying degrees of h
eart block have been reported. Although second degree block has, on rave oc
casion, reverted to normal sinus rhythm, complete atrio-ventricular (AV) bl
ock is irreversible. CHB carr-ies substantial mortality and morbidity, with
>60% of affected children requiring lifelong pacemakers. The recurrence I-
ate exceeds, by at least twofold, that of the fit-st birth and is likely to
influence the decision to have more children. Curiously the mother's heart
is almost never affected (with complete heart block) despite exposure to i
dentical circulating autoantibodies. As part of our continuing effort to un
derstand the complex factors contributing to the pathogenesis of CHB, we ha
ve established an animal model of CHB by immunizing female mice with recomb
inant proteins/antigens, reproduced the human complete AV block in an isola
ted Langendorff perfused fetal heart, and correlated these findings with L-
type Ca channel inhibition bq, maternal antibodies front mothers of childre
n with CHB. In addition, we established a passive animal model by directly
injecting maternal antibodies into pregnant mice and reported significant s
inus bradycardia, indicating that the spectrum of conduction abnormalities
may extend beyond the AV node. All together, the data provided strong evide
nce supporting an etiologic role of antibody/Ca channel involvement in the
pathogenesis of CHB. However; other vet unknown factors seem necessary, to
explain the full expression of CHB, (C) 2001, Elsevier Science Inc.